{
    "clinical_study": {
        "@rank": "166575", 
        "arm_group": [
            {
                "arm_group_label": "Control", 
                "arm_group_type": "Other", 
                "description": "One area assessed as a control area, compared to the laser-treated area"
            }, 
            {
                "arm_group_label": "Non-ablative Laser treatment", 
                "arm_group_type": "Active Comparator", 
                "description": "3 Non-ablative fractional laser treatments of one area"
            }
        ], 
        "brief_summary": {
            "textblock": "BACKGROUND: Increasing evidence appears for non-ablative fractional laser (NAFL) to remodel\n      mature burn scars.\n\n      OBJECTIVES: To investigate long-term clinical and histological appearance of mature burn\n      scars after NAFL-treatment.\n\n      HYPOTHESIS: That NAFL can modulate mature burn scars with subsequently improved cosmetic and\n      functional appearance.\n\n      METHODS: Study patients with burn scars at trunk or extremities. Side-by-side test areas are\n      randomized to three monthly 1,540 nm NAFL-treatments or control, followed by blinded\n      evaluations at 1, 3, and 6 months using mPOSAS (modified Patient and Observer Scar\n      Assessment Scale; 1 = normal skin, 10 = worst imaginable scar)."
        }, 
        "brief_title": "Non Ablative Fractional Laser Treatment of Burn Scars", 
        "completion_date": {
            "#text": "October 2012", 
            "@type": "Actual"
        }, 
        "condition": "Burn Scars", 
        "condition_browse": {
            "mesh_term": [
                "Burns", 
                "Cicatrix"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  legally competent adults aged 18-60 years\n\n          -  Fitzpatrick skin type I-III\n\n          -  burn scar 1 year or older\n\n          -  total scar area allowing selection of two similar side-by-side test areas of minimum\n             1.5 \u00d7 3 cm for study purpose\n\n        Exclusion Criteria:\n\n          -  pregnancy or lactation\n\n          -  suntan\n\n          -  wounds or infections in study area\n\n          -  tendency to form hypertrophic scars or keloids\n\n          -  oral retinoids, anti-inflammatory or immunosuppressive drugs within the last six\n             months\n\n          -  current anticoagulants\n\n          -  previous treatments in test area with laser, Intense Pulsed Light, dermabrasion,\n             chemical peel or filler."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "60 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "20", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "December 12, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02014298", 
            "org_study_id": "H3-2009-149"
        }, 
        "intervention": [
            {
                "arm_group_label": "Control", 
                "description": "3 treatments with 4-6 weeks interval", 
                "intervention_name": "non-ablative fractional laser", 
                "intervention_type": "Radiation", 
                "other_name": [
                    "non-ablative fractional er:glass laser", 
                    "1,540 nm laser treatment"
                ]
            }, 
            {
                "arm_group_label": "Non-ablative Laser treatment", 
                "description": "observation, comparison to laser-treated area", 
                "intervention_name": "control", 
                "intervention_type": "Other", 
                "other_name": "observation"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "Burns", 
            "Non-ablative fractional laser", 
            "scar texture", 
            "histology", 
            "laser treatment", 
            "erbium:glass laser", 
            "meshed skin-grafts", 
            "photothermolysis", 
            "skin"
        ], 
        "lastchanged_date": "December 12, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Copenhagen NV", 
                    "country": "Denmark", 
                    "state": "Copenhagen", 
                    "zip": "DK-2400"
                }, 
                "name": "Bispebjerg Hospital, University of Copenhagen"
            }
        }, 
        "location_countries": {
            "country": "Denmark"
        }, 
        "number_of_arms": "2", 
        "official_title": "LONG-TERM AND CONTINUED IMPROVEMENT OF MATURE BURN SCARS IN RESPONSE TO NONABLATIVE FRACTIONAL LASER - A RANDOMIZED CONTROLLED TRIAL WITH HISTOLOGICAL EVALUATION", 
        "overall_official": {
            "affiliation": "Bispebjerg Hospital, University of Copenhagen", 
            "last_name": "Merete H\u00e6dersdal, MD,PhD,DmSc", 
            "role": "Study Director"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Denmark: Ethics Committee", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "October 2012", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "Primary endpoint is change in overall scar-appearance assessed by a slightly modified Patient and Observer Scar Assessment Scale (evaluation of study area omitted since this is fixed as part of study procedure). Scale: 1= normal skin; 10= worst imaginable scar.", 
            "measure": "Change in overall Scar-appearance", 
            "safety_issue": "No", 
            "time_frame": "1,3 and 6 months follow-up"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02014298"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Bispebjerg Hospital", 
            "investigator_full_name": "Elisabeth Taudorf", 
            "investigator_title": "MD", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "Additional assessments include:\nevaluation of vascularity, pigmentation, thickness, relief, pliability (evaluated on modified Patient and Observer Scar Assessment Scale)\nhistological changes (Small safety issue from taking a 4 mm cutaneous punch biopsy)\npatient satisfaction\nadverse events (pain during treatment, immediate treatment reaction, 24h treatment reaction, evaluation of side effects at 6 months follow-up)", 
            "measure": "specific clinical and histological scar appearance", 
            "safety_issue": "Yes", 
            "time_frame": "1, 3, and 6 months follow-up"
        }, 
        "source": "Bispebjerg Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Bispebjerg Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "December 2013"
    }
}